Rhythm Pharmaceuticals (RYTM) Stock Price, Quote, News & History | Benzinga

Rhythm Pharmaceuticals Inc (RYTM) Stock Price, Quote, News & History

RYTMNASDAQ

Trade with Public

Trade with Public

$115.44

-0.04-0.03%

At close: Aug 17, 5:00 PM EST

$115.44

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$115.40

Close

$115.44

Volume / Avg.

412.05K / 774.81K

Day Range

$114.44 - $117.18

52 Wk Range

74.50 - 122.20

Market Cap

$7.95B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

13.82%

Days to Cover

16.17

Recent Rhythm Pharmaceuticals, Inc. News

Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday?

Rhythm Pharma shares rise after U.K. expands Imcivree authorization for acquired hypothalamic obesity in adults and children 4 and older.

Vandana Singh

Why Is Rhythm Pharma Stock Jumping Today?

Rhythm Pharma Phase 2 data showed improvements in BMI, body composition, hunger symptoms, and behavior in PWS patients.

Vandana Singh

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported better-than-expected earnings, with strong demand for IMCIVREE and potential launches in Europe and Japan.

Avi Kapoor

Rhythm Pharma Wins FDA Approval For First-Ever Rare Weight Disorder Therapy

FDA expands Rhythm Pharmaceuticals Imcivree approval for rare hypothalamic obesity, showing strong weight loss results.

Vandana Singh

Why Playboy Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Playboy (PLBY) shares rise in pre-market trading after reporting better-than-expected Q4 results. Other gainers include PTOR, LNAI, LIDR, ISPC, WNW, JVA, NUAI, XLO, and BW. Losers include PRSO, DFLI, LNSR, and MVST.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-105.35M

Investing Cash Flow (TTM)

-144.94M

Financing Cash Flow (TTM)

179.79M

Free Cash Flow (TTM)

-106.30M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-70.50M

Analyst Trends and Forecast

3

May

2

Jun

2

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.73B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

32.45

PB Ratio (TTM)

77.17

Earnings Yield % (TTM)

-2.70%

Earnings Yield % (FWD)

-2.55%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.50

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$65.61M

Debt to Equity

0.04

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$115.40

Close

$115.44

Volume / Avg.

412.05K / 774.81K

Day Range

$114.44 - $117.18

52 Wk Range

74.50 - 122.20

Market Cap

$7.95B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

13.82%

Days to Cover

16.17

About

Sector

Health Care

Industry

Biotechnology

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Rhythm Pharmaceuticals (RYTM) stock?

A

You can purchase shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Rhythm Pharmaceuticals (RYTM) competitors?

A

Other companies in Rhythm Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Rhythm Pharmaceuticals (RYTM) stock?

A

Rhythm Pharmaceuticals has a consensus price target of $131.94.

Q

What is the current price for Rhythm Pharmaceuticals (RYTM)?

A

The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $115.44 last updated August 17, 2026 at 4:00 PM EDT.

Q

Does Rhythm Pharmaceuticals (RYTM) pay a dividend?

A

There are no upcoming dividends for Rhythm Pharmaceuticals.

Q

When is Rhythm Pharmaceuticals (NASDAQ:RYTM) reporting earnings?

A

Rhythm Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Rhythm Pharmaceuticals (RYTM) going to split?

A

There is no upcoming split for Rhythm Pharmaceuticals.

Q

What sector and industry does Rhythm Pharmaceuticals (RYTM) operate in?

A

Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.